2.870NOK-5.59%Mkt Cap: 7.23M $P/E: —Today
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europ…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap7.23M $
Enterprise Value13.37M $
Revenue (TTM)3.98M $
Gross Profit1.03M $
Net Income (TTM)-3.84M $
Revenue/Share0.1476 USD
Last Price2.870 NOK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees19
CountryNO
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-14.00
PEG—
EV/EBITDA-4.67
EV/Revenue3.35
P/S1.77
P/B0.44
EPS (TTM)-1.52
EPS (Forward)-0.20
52W Range
2.51017% of range4.650
52W High4.650 NOK
52W Low2.510 NOK
Profitability
Gross Margin27.54%
Oper. Margin-72.20%
EBITDA Margin-71.79%
Profit Margin-102.32%
ROE-23.65%
ROA-14.41%
Growth
Revenue Growth-12.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.12M $
CapEx (TTM)2.13M $
FCF Margin-84.68%
FCF Yield-46.65%
Net Debt5.71M $
Net Debt/EBITDA-1.99
Balance Sheet
Debt/Equity0.37
Current Ratio0.59
Quick Ratio0.24
Book Value/Sh6.436 NOK
Cash/Share0.0480 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.26.96M
Float12.29M
Insiders52.25%
Institutions1.44%
Technical
SMA 503.086 (-7.0%)
SMA 2003.337 (-14.0%)
Beta1.07
S&P 52W Chg18.16%
Avg Vol (30d)15.17K
Avg Vol (10d)12.24K
Technical Indicators
RSI (14)51.2
MACD-0.0118
MACD Signal-0.0360
MACD Hist.+0.0241
BB Upper3.240 NOK
BB Middle2.919 NOK
BB Lower2.598 NOK
BB Width22.02%
ATR (14)0.2272 NOK
Vol Ratio (20d)0.15x